[HTML][HTML] Epidemiology of peritoneal dialysis outcomes

AK Bello, IG Okpechi, MA Osman, Y Cho… - Nature Reviews …, 2022 - nature.com
Peritoneal dialysis (PD) is an important home-based treatment for kidney failure and
accounts for 11% of all dialysis and 9% of all kidney replacement therapy globally. Although …

The current state of peritoneal dialysis

R Mehrotra, O Devuyst, SJ Davies… - Journal of the American …, 2016 - journals.lww.com
Technical innovations in peritoneal dialysis (PD), now used widely for the long-term
treatment of ESRD, have significantly reduced therapy-related complications, allowing …

International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis

EA Brown, PG Blake, N Boudville… - Peritoneal Dialysis …, 2020 - journals.sagepub.com
Background The International Society for Peritoneal Dialysis (ISPD) last published
guidelines on prescribing peritoneal dialysis (PD) in 2006. 1 These focused primarily on …

[HTML][HTML] Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

JE Flythe, TI Chang, MP Gallagher, E Lindley… - Kidney international, 2020 - Elsevier
Blood pressure (BP) and volume control are critical components of dialysis care and have
substantial impacts on patient symptoms, quality of life, and cardiovascular complications …

ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: classification, measurement, interpretation and rationale for intervention

J Morelle, J Stachowska-Pietka… - Peritoneal Dialysis …, 2021 - journals.sagepub.com
Lay summary Peritoneal dialysis (PD) uses the peritoneal membrane for dialysis. The
peritoneal membrane is a thin layer of tissue that lines the abdomen. The lining is used as a …

[HTML][HTML] Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical …

D Banerjee, P Winocour, TA Chowdhury, P De… - BMC nephrology, 2022 - Springer
People with type 1 and type 2 diabetes are at risk of developing progressive chronic kidney
disease (CKD) and end-stage kidney failure. Hypertension is a major, reversible risk factor …

Biocompatible dialysis fluids for peritoneal dialysis

H Htay, DW Johnson, KJ Wiggins… - Cochrane Database …, 2018 - cochranelibrary.com
Background Biocompatible peritoneal dialysis (PD) solutions, including neutral pH, low
glucose degradation product (GDP) solutions and icodextrin, have previously been shown to …

[HTML][HTML] Hypertension in patients on dialysis: diagnosis, mechanisms, and management

SGE Bucharles, KKS Wallbach, TP Moraes… - Brazilian Journal of …, 2018 - SciELO Brasil
Abstract Hypertension (blood pressure> 140/90 mm Hg) is very common in patients
undergoing regular dialysis, with a prevalence of 70-80%, and only the minority has …

Rationale and strategies for preserving residual kidney function in dialysis patients

T Li, CS Wilcox, MS Lipkowitz… - American journal of …, 2019 - karger.com
Background: Residual kidney function (RKF) conveys a survival benefit among dialysis
patients, but the mechanism remains unclear. Improved volume control, clearance of protein …

[HTML][HTML] Incremental versus standard (full-dose) peritoneal dialysis

MS Cheetham, Y Cho, R Krishnasamy, AK Jain… - Kidney International …, 2022 - Elsevier
Incremental peritoneal dialysis (PD), defined as less than “standard dose” PD prescription,
has a number of possible benefits, including better preservation of residual kidney function …